Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.

Lourdes G Merlo, Saba Ansari, Bhupinder Singh, Fikerte F Teferedgin, Kelly L Cervellione, Jonas Gintautas, Mohammad A Babury
{"title":"Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.","authors":"Lourdes G Merlo,&nbsp;Saba Ansari,&nbsp;Bhupinder Singh,&nbsp;Fikerte F Teferedgin,&nbsp;Kelly L Cervellione,&nbsp;Jonas Gintautas,&nbsp;Mohammad A Babury","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The administration of fibrinolytic agents in the pleural cavity is an alternative treatment for the management of loculated empyemas in patients who are poor candidates for surgery and/or do not respond to more standard treatments (e.g., chest tube placement, pleurodesis). Unfortunately, in practice it is not frequently offered as an alternative treatment approach. Here we present the case of a 79-year-old male with right lower lobe pneumonia complicated by a parapneumonic pleural effusion that showed minimal improvement after chest tube placement and broad-spectrum antibiotic treatment. Intrapleural tissue plasminogen activator (tPA) was administered daily for three consecutive days, which resulted in the breakdown of intrapleural loculations and facilitation of drainage, followed by significant clinical and radiologic improvement. tPA was successful in the treatment of parapneumonic pleural effusions in a patient who was not a candidatefor surgical intervention and who failed to respond to standard treatments.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the Western Pharmacology Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The administration of fibrinolytic agents in the pleural cavity is an alternative treatment for the management of loculated empyemas in patients who are poor candidates for surgery and/or do not respond to more standard treatments (e.g., chest tube placement, pleurodesis). Unfortunately, in practice it is not frequently offered as an alternative treatment approach. Here we present the case of a 79-year-old male with right lower lobe pneumonia complicated by a parapneumonic pleural effusion that showed minimal improvement after chest tube placement and broad-spectrum antibiotic treatment. Intrapleural tissue plasminogen activator (tPA) was administered daily for three consecutive days, which resulted in the breakdown of intrapleural loculations and facilitation of drainage, followed by significant clinical and radiologic improvement. tPA was successful in the treatment of parapneumonic pleural effusions in a patient who was not a candidatefor surgical intervention and who failed to respond to standard treatments.

右下肺叶肺炎继发的局限性肺旁胸腔积液的纤溶治疗。
对于不适合手术治疗和/或对标准治疗(如胸管置入术、胸膜切除术)无效的患者,胸膜腔内给予纤溶剂是一种可选的治疗方法。不幸的是,在实践中,它并不经常作为一种替代治疗方法提供。我们在此报告一例79岁男性右下肺叶肺炎合并肺旁胸腔积液,经胸腔置管及广谱抗生素治疗后病情改善很小。连续3天每天给予胸膜组织纤溶酶原激活剂(tPA),导致胸膜内定位破裂和引流便利,随后临床和放射学显著改善。tPA成功地治疗了一位不适合手术治疗且对标准治疗无效的患者的肺旁胸腔积液。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信